Clinical Trial

New Strategy to Predict Early Sepsis

Study Description

New Strategy to Predict Early Sepsis

This is an observational prospective multicentre study on patients attending the emergency department and suspected to have sepsis. Blood markers characteristic of a Cellular Reprogramming (CR) signature and predicting severe sepsis and organ failure will be measured and validated.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Blood sample collection

A blood sample (1 tube) will be collected for the analysis of the CR signature.

Additional Information

Official Study Title

Development of a New Strategy to Predict Early Sepsis

Clinical Trial ID

NCT04118179

ParticipAid ID

aM8rAe